Edwards Lifesciences Corporation
EW
$85.28
-$1.90-2.18%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.23B | 3.84B | 4.06B | 3.90B | 3.98B |
| Total Receivables | 912.10M | 892.80M | 902.60M | 751.90M | 727.40M |
| Inventory | 1.13B | 1.14B | 1.14B | 1.11B | 1.09B |
| Prepaid Expenses | 135.00M | 125.20M | 110.00M | 111.30M | 121.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 339.30M | 358.00M | 360.70M | 337.10M | 374.40M |
| Total Current Assets | 6.74B | 6.36B | 6.58B | 6.21B | 6.29B |
|
|
|||||
| Total Current Assets | 6.74B | 6.36B | 6.58B | 6.21B | 6.29B |
| Net Property, Plant & Equipment | 1.91B | 1.84B | 1.83B | 1.80B | 1.78B |
| Long-term Investments | 1.77B | 1.77B | 1.78B | 1.78B | 1.78B |
| Goodwill | 1.77B | 1.77B | 1.78B | 1.78B | 1.78B |
| Total Other Intangibles | 1.13B | 1.13B | 1.17B | 1.17B | 1.18B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.87B | 1.90B | 1.84B | 1.78B | 1.72B |
| Total Assets | 13.70B | 13.27B | 13.49B | 13.02B | 13.06B |
|
|
|||||
| Total Accounts Payable | 227.50M | 165.00M | 162.10M | 172.40M | 197.40M |
| Total Accrued Expenses | 1.07B | 907.70M | 839.10M | 624.30M | 790.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 24.50M | 26.80M | 25.90M | 23.70M | 23.40M |
| Total Finance Division Other Current Liabilities | 496.70M | 488.50M | 377.60M | 574.40M | 494.00M |
| Total Other Current Liabilities | 496.70M | 488.50M | 377.60M | 574.40M | 494.00M |
| Total Current Liabilities | 1.81B | 1.59B | 1.40B | 1.39B | 1.51B |
|
|
|||||
| Total Current Liabilities | 1.81B | 1.59B | 1.40B | 1.39B | 1.51B |
| Long-Term Debt | 598.30M | 598.20M | 598.00M | 597.80M | 597.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 82.60M | 75.30M | 78.70M | 77.90M | 78.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 865.00M | 805.70M | 800.80M | 760.20M | 810.60M |
| Total Liabilities | 3.36B | 3.07B | 2.88B | 2.83B | 2.99B |
|
|
|||||
| Common Stock & APIC | 3.43B | 3.36B | 3.41B | 3.31B | 3.27B |
| Retained Earnings | 14.24B | 14.15B | 13.86B | 13.53B | 13.17B |
| Treasury Stock & Other | -7.33B | -7.30B | -6.72B | -6.71B | -6.44B |
| Total Common Equity | 10.34B | 10.21B | 10.55B | 10.13B | 10.00B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.34B | 10.21B | 10.55B | 10.13B | 10.00B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | 61.20M | 62.90M | 64.50M |
| Total Equity | 10.34B | 10.21B | 10.61B | 10.19B | 10.06B |
|
|
|||||